Dr. Mallory is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Forest Glen Rd
Silver Spring, MD 20910
Education & Training
Yale School of MedicineClass of 1997
Certifications & Licensure
MD State Medical License 2002 - 2015
Clinical Trials
- A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years. Start of enrollment: 2003 Jun 01
- Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children Start of enrollment: 2000 Oct 01
Publications & Presentations
PubMed
- 53 citationsSafety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled TrialsRaburn M. Mallory, Elissa Malkin, Christopher S. Ambrose, Terramika Bellamy, Li Shi
Plos One. 2010-10-29 - 33 citationsShedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.Raburn M. Mallory, Tingting Yi, Christopher S. Ambrose
Vaccine. 2011-06-10 - 41 citationsEvaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated InfluenzaS. Omar Ali, Therese Takas, Andrew C. Nyborg, Kathryn Shoemaker, Nicole L. Kallewaard
Antimicrobial Agents and Chemotherapy. 2018-10-24
Journal Articles
- A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Healthy Adult Volunteers☆Raburn M Mallory, Martin Kankam, ScienceDirect
Press Mentions
Novavax Reports Third Quarter 2021 Financial Results and Operational HighlightsNovember 4th, 2021
FluMist Vaccine Approved by CDC Without Proof It Works as AdvertisedOctober 3rd, 2018
It’s OK to Use Nasal Spray Flu Vaccine Again, US Panel SaysFebruary 21st, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
